Cargando…

Resident Factors Associated With Breakthrough SARS-CoV-2 Infections

OBJECTIVE: To examine incidence of and resident characteristics associated with breakthrough infections (BTIs) and severe illness among residents with 2 messenger RNA (mRNA) vaccinations. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Nursing home (NH) residents who completed their pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montoya, Ana, Wen, Katherine, Travers, Jasmine L., Rivera-Hernandez, Maricruz, White, Elizabeth, Mor, Vincent, Berry, Sarah D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2023
Materias:	Original Study - Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977610/ https://www.ncbi.nlm.nih.gov/pubmed/36965506 http://dx.doi.org/10.1016/j.jamda.2023.02.102

Ejemplares similares

Factors Affecting SARS-CoV-2 Test Discordance in Skilled Nursing Facilities
por: Recker, Amy, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
por: Uschner, Diane, et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8(+) and CD4(+) T cells of broad specificity
por: Lim, Joey Ming Er, et al.
Publicado: (2022)

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)

RACIAL DISPARITIES IN 30-DAY READMISSION RATES AMONG MEDICARE PATIENTS DISCHARGED TO SKILLED NURSING FACILITIES
por: Rivera-Hernandez, Maricruz, et al.
Publicado: (2019)

Incidence and Outcomes of SARS-CoV-2 in Post-Acute Skilled Nursing Facility Care
por: Ritter, Ashley Z., et al.
Publicado: (2022)

Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
por: Galán-Huerta, Kame A., et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants
por: Tuffy, Kevin M, et al.
Publicado: (2023)

Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents
por: White, Elizabeth M., et al.
Publicado: (2021)

SARS-CoV-2 Breakthrough Infections after Third Doses Boost IgG Specific Salivary and Blood Antibodies
por: Badano, María Noel, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
por: McEwen, Abbye E, et al.
Publicado: (2021)

In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center
por: Rümke, Lidewij W, et al.
Publicado: (2021)

ACHIEVING EQUITABLE QUALITY OF CARE FOR NURSING HOME RESIDENTS
por: Travers, Jasmine
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection
por: Kim, Heui Man, et al.
Publicado: (2023)

SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
por: Aldridge, Robert W., et al.
Publicado: (2022)

Cross-reactive tissue-resident CD8(+) T cells may provide first line of defence against SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus
por: Wu, Kevin E., et al.
Publicado: (2020)

Assessment of Coronavirus Disease 2019 Infection and Mortality Rates Among Nursing Homes With Different Proportions of Black Residents
por: Travers, Jasmine L., et al.
Publicado: (2021)

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
por: Fu, Jolene Yin Ling, et al.
Publicado: (2023)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Trends and Correlates of Breakthrough Infections With SARS-CoV-2
por: Yamal, Jose-Miguel, et al.
Publicado: (2022)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

SARS-CoV-2 vaccine safe for young patients
por: Onuora, Sarah
Publicado: (2022)

SARS-CoV-2 has a sweet tooth
por: Cavounidis, Athena, et al.
Publicado: (2020)

Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias
por: Meyers, David J., et al.
Publicado: (2021)

Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022)

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
por: Canaday, David H, et al.
Publicado: (2021)

Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults
por: Wolff, Marcelo, et al.
Publicado: (2022)

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity
por: Pollett, Simon D, et al.
Publicado: (2021)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

Archetype of Olfactory and Gustatory Dysfunction in Breakthrough COVID-19 Illness
por: Sagar, Prem, et al.
Publicado: (2021)

Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
por: Hall, Victoria G, et al.
Publicado: (2023)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b99d2gnbhi2fklco4ed5lbg2pq